NOTCH3 and non-small cell lung carcinoma: Importantly, in mouse models of non-small cell lung cancer, disruption of the NOTCH3 enhancer significantly suppresses tumor progression and augments the anticancer effects of cisplatin, demonstrating the important role of the NOTCH3 enhancer in tumorigenesis and drug resistance [11].